These data are consistent with more recent studies showing that CBL0137 can transcriptionally downregulate MYC expression via inhibition of the enhancer-promoter communication in neuroblastoma and medulloblastoma [17, 19, 22]. The gene discussed is MYC; the disease is medulloblastoma.